38.83 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EDT)
Novo-Nordisk A/S
NVONYSE • USD
38.76
↘ 0.07 (0.18%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
38.76
↘ 0.07 (0.18%)
Market: CLOSED
NVO is currently priced at $38.73. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 16, 2026.
Open?$39.33
High?$39.40
Low?$38.67
Prev. Close?$38.83
Volume?10.8M
Avg. Volume?N/A
VWAP?$39.02
Bid / Ask
Bid?$38.71 × 200
Ask?$38.81 × 100
Spread?$0.10
Midpoint?$38.76
Valuation & Ratios
Market Cap?171.4B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Themes
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?31.6M
Days to Cover?1.7
Avg Daily Volume18.2M
Settlement Date2026-09-30